OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
CVT57

Comvita Ltd

Food ProcessingVerified

Comvita's capital structure is characterized by a lack of dilution risk, as the number of basic and diluted shares outstanding is identical at 116,680,534 shares. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and returns data are not available in the current valuation snapshot, making it difficult to compare Comvita's performance against industry_config preferred metrics or cohort medians. This lack of data limits the ability to assess the company's financial health relative to its peers. Comvita's revenue concentration and geographic exposure are not disclosed in the available data, which limits the ability to assess the company's risk from over-reliance on specific markets or customer segments. The company's growth trajectory is unclear due to the absence of revenue history and outlook data. Analysts have provided a single "Hold" recommendation with a mean price target of 0.78 NZD, but no strong buy or buy ratings have been issued. Risk factors include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. There is no indication of dilution potential in the near term, as the number of diluted shares is equal to the number of basic shares. Recent events and filings do not provide additional insight into the company's operations or strategic direction. The lack of detailed financial disclosures and analyst activity suggests limited transparency and market engagement.

30-day price · CVT+0.06 (+9.3%)
Low$0.64High$0.76Close$0.71As of15 May, 00:00 UTC
Profile
CompanyComvita Ltd
TickerCVT.NZ
SectorConsumer Non-Cyclicals
BusinessFood & Beverages
Industry groupFood & Beverages
IndustryFood Processing
AI analysis

Business. Comvita Ltd is a New Zealand-based company that produces and distributes natural health and wellness products, primarily focusing on honey-based products and other natural remedies.

Classification. Comvita is classified under the Consumer Non-Cyclicals economic sector, Food & Beverages business sector, and Food Processing industry, with a classification confidence of 0.92.

Comvita's capital structure is characterized by a lack of dilution risk, as the number of basic and diluted shares outstanding is identical at 116,680,534 shares. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and returns data are not available in the current valuation snapshot, making it difficult to compare Comvita's performance against industry_config preferred metrics or cohort medians. This lack of data limits the ability to assess the company's financial health relative to its peers. Comvita's revenue concentration and geographic exposure are not disclosed in the available data, which limits the ability to assess the company's risk from over-reliance on specific markets or customer segments. The company's growth trajectory is unclear due to the absence of revenue history and outlook data. Analysts have provided a single "Hold" recommendation with a mean price target of 0.78 NZD, but no strong buy or buy ratings have been issued. Risk factors include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. There is no indication of dilution potential in the near term, as the number of diluted shares is equal to the number of basic shares. Recent events and filings do not provide additional insight into the company's operations or strategic direction. The lack of detailed financial disclosures and analyst activity suggests limited transparency and market engagement.
Key takeaways
  • Comvita operates in the natural health and wellness sector with a focus on honey-based products.
  • The company shows no dilution risk based on current share data.
  • Liquidity risk cannot be assessed due to missing balance-sheet data.
  • Analysts have issued a single "Hold" recommendation with a mean price target of 0.78 NZD.
  • Growth trajectory and profitability metrics are not available for comparison with industry benchmarks.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyNZD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$191.7M$12.2M$9.5M$9.1M
FY-3$208.9M$20.1M$12.8M$9.6M
FY-2$234.2M$23.9M$11.1M-$1.2M
FY-1$200.7M-$75.5M-$80.4M-$79.8M
FY0$192.4M-$86.4M-$104.8M-$95.9M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$286.6M$221.9M
FY-3$332.8M$228.0M
FY-2$358.8M$239.3M
FY-1$303.7M$156.7M$8.2M
FY0$173.3M$54.9M$9.0M
PeriodOCFCapExFCFSBC
FY-4$24.8M-$11.0M$9.1M
FY-3$2.8M-$9.4M$9.6M
FY-2$8.1M-$20.4M-$1.2M
FY-1$5.3M-$9.7M-$79.8M
FY0$34.1M-$3.3M-$95.9M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Food Processing · cohort 1040 companies
MetricCVTActivity
Op margin5.6% medp25 2.1% · p75 11.2%
Net margin3.9% medp25 0.5% · p75 8.5%
Gross margin23.3% medp25 14.8% · p75 32.6%
R&D / revenue0.8% medp25 0.5% · p75 2.3%
CapEx / revenue-4.1% medp25 -8.9% · p75 -1.9%
Debt / equity37.6% medp25 7.2% · p75 84.5%
Observations
IR observations
Mean price target0.78 NZD
Median price target0.78 NZD
High price target0.78 NZD
Low price target0.78 NZD
Mean recommendation3.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count0.00
Hold count1.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.08 NZD
Last actual EPS-0.45 NZD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 03:35 UTC#927b3c1e
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 17:44 UTCJob: af0e6ad0